These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17643757)

  • 1. Pacing the marathon: rate of decline of pulmonary function in cystic fibrosis.
    Davis PB
    J Pediatr; 2007 Aug; 151(2):111-3. PubMed ID: 17643757
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.
    Assael BM; Casazza G; Iansa P; Volpi S; Milani S
    Pediatr Pulmonol; 2009 Mar; 44(3):209-15. PubMed ID: 19230003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of mortality from cystic fibrosis.
    Baghaie N; Kalilzadeh S; Hassanzad M; Parsanejad N; Velayati A
    Pneumologia; 2010; 59(3):170-3. PubMed ID: 21053647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cystic fibrosis--examination of the role of allergic bronchopulmonary aspergillosis].
    Klein F
    Pneumologie; 2007 Oct; 61(10):628. PubMed ID: 17922386
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-invasive tension time index in relation to severity of disease in children with cystic fibrosis.
    Hahn A; Ankermann T; Claass A; Mann M; Lindemann H; Neubauer BA
    Pediatr Pulmonol; 2008 Oct; 43(10):973-81. PubMed ID: 18780334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent exacerbations affect FEV(1) decline in adult patients with cystic fibrosis.
    Amadori A; Antonelli A; Balteri I; Schreiber A; Bugiani M; De Rose V
    Respir Med; 2009 Mar; 103(3):407-13. PubMed ID: 19027279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis.
    Horsley AR; Gustafsson PM; Macleod KA; Saunders C; Greening AP; Porteous DJ; Davies JC; Cunningham S; Alton EW; Innes JA
    Thorax; 2008 Feb; 63(2):135-40. PubMed ID: 17675315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary outcome prediction for cystic fibrosis patients.
    Kraemer R; Thamrin C
    Pediatr Pulmonol; 2010 Dec; 45(12):1153-5. PubMed ID: 20845499
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cystic fibrosis lung disease on gas mixing indices derived from alveolar slope analysis.
    Horsley AR; Macleod KA; Robson AG; Lenney J; Bell NJ; Cunningham S; Greening AP; Gustafsson PM; Innes JA
    Respir Physiol Neurobiol; 2008 Aug; 162(3):197-203. PubMed ID: 18625345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S; Jones A; Brownlee K
    Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New approaches in antibiotic therapies in chronic pulmonary diseases].
    Celik U; Kocabas E
    Tuberk Toraks; 2008; 56(3):353-63. PubMed ID: 18932040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral infections trigger exacerbations of cystic fibrosis in adults and children.
    Wark PA; Tooze M; Cheese L; Whitehead B; Gibson PG; Wark KF; McDonald VM
    Eur Respir J; 2012 Aug; 40(2):510-2. PubMed ID: 22855475
    [No Abstract]   [Full Text] [Related]  

  • 16. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.
    Robinson PD; Cooper P; Van Asperen P; Fitzgerald D; Selvadurai H
    Pediatr Pulmonol; 2009 Aug; 44(8):733-42. PubMed ID: 19598271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pulmonary function in fibrocystic disease of the pancreas].
    Baran D; Englert M
    Poumon Coeur; 1970; 26(5):615-24. PubMed ID: 5509507
    [No Abstract]   [Full Text] [Related]  

  • 18. Airway ion transport impacts on disease presentation and severity in cystic fibrosis.
    Leal T; Fajac I; Wallace HL; Lebecque P; Lebacq J; Hubert D; Dall'Ava J; Dusser D; Ganesan AP; Knoop C; Cumps J; Wallemacq P; Southern KW
    Clin Biochem; 2008 Jul; 41(10-11):764-72. PubMed ID: 18424267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between nutritional status and pulmonary function in adult cystic fibrosis patients.
    Gozdzik J; Cofta S; Piorunek T; Batura-Gabryel H; Kosicki J
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():253-60. PubMed ID: 19218649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung clearance index in CF: a sensitive marker of lung disease severity.
    Davies JC; Cunningham S; Alton EW; Innes JA
    Thorax; 2008 Feb; 63(2):96-7. PubMed ID: 18234652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.